Baxter Ventures acquires minority stake in healthcare company and backs $8.5m series E funding alongside Ascension Health Ventures.
Ocular Therapeutix, a US-based healthcare company focused on the development and commercialization of ophthalmic therapeutic products, has secured series E funding of $8.5m from Ascension Health Ventures, a subsidiary of hospital group Ascension Health, and Baxter Ventures, a subsidiary of healthcare company Baxter International. Baxter Ventures has also acquired a minority equity stake in Ocular Therapeutix.
This round of financing takes Ocular Therapeutix’s total funding to $54.5m, following its series D extension of nearly $10m, which closed in November 2012.…
